Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Elizabeth McFarland

Concepts (375)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV-1
26
2025
834
2.950
Why?
HIV Infections
48
2025
2711
2.950
Why?
Respiratory Syncytial Virus Vaccines
6
2022
34
2.400
Why?
Respiratory Syncytial Virus Infections
6
2022
119
2.210
Why?
Respiratory Syncytial Virus, Human
6
2022
68
2.200
Why?
Infectious Disease Transmission, Vertical
18
2025
170
2.180
Why?
HIV Antibodies
12
2025
57
2.100
Why?
Anti-Retroviral Agents
12
2023
231
1.770
Why?
Viral Proteins
3
2020
323
1.620
Why?
Antibodies, Viral
8
2022
601
1.160
Why?
Antibodies, Neutralizing
8
2025
264
1.130
Why?
Antibodies, Monoclonal
6
2025
1357
0.910
Why?
Anti-HIV Agents
11
2025
751
0.900
Why?
AIDS Vaccines
8
2018
47
0.880
Why?
Pregnancy Complications, Infectious
8
2016
364
0.790
Why?
Gene Deletion
2
2020
370
0.740
Why?
Breast Feeding
4
2025
422
0.670
Why?
Atazanavir Sulfate
2
2017
41
0.650
Why?
HIV Protease Inhibitors
2
2017
64
0.640
Why?
Ritonavir
2
2017
72
0.630
Why?
Infant, Newborn
23
2025
5740
0.600
Why?
Vaccination
6
2020
1346
0.600
Why?
Vaccines, Attenuated
6
2022
125
0.590
Why?
HIV Envelope Protein gp120
6
2017
57
0.590
Why?
Infant
31
2025
9001
0.530
Why?
Nelfinavir
1
2016
9
0.520
Why?
Lopinavir
1
2016
30
0.510
Why?
Syncope
1
2016
50
0.510
Why?
Patient Dropouts
1
2016
64
0.510
Why?
Bradycardia
1
2016
53
0.500
Why?
Lyme Disease
1
2016
55
0.490
Why?
Health Resources
1
2016
113
0.480
Why?
Infant, Newborn, Diseases
1
2016
109
0.460
Why?
HIV
5
2014
226
0.430
Why?
Patient Compliance
2
2018
560
0.410
Why?
Child
37
2025
20805
0.390
Why?
Immunogenicity, Vaccine
4
2021
27
0.390
Why?
CD4-Positive T-Lymphocytes
2
2017
1045
0.370
Why?
Humans
72
2025
128499
0.370
Why?
T-Lymphocytes, Cytotoxic
4
2005
168
0.370
Why?
Virus Replication
4
2020
444
0.370
Why?
Female
48
2025
68268
0.360
Why?
Lymphocyte Activation
5
2017
1098
0.320
Why?
Male
39
2025
63045
0.320
Why?
Adolescent
27
2025
20304
0.300
Why?
Viral Load
9
2017
449
0.290
Why?
HIV Seropositivity
2
2023
119
0.280
Why?
Bone Density
2
2025
474
0.280
Why?
Double-Blind Method
3
2020
1856
0.270
Why?
RNA, Viral
8
2023
615
0.260
Why?
Antibodies, Bacterial
2
2018
137
0.250
Why?
Antiretroviral Therapy, Highly Active
6
2017
266
0.240
Why?
Dyslipidemias
2
2017
176
0.240
Why?
Bone Development
1
2025
49
0.240
Why?
Immunoenzyme Techniques
1
2005
205
0.230
Why?
Immunoglobulin G
3
2022
844
0.230
Why?
Colonography, Computed Tomographic
1
2024
6
0.220
Why?
Viremia
3
2011
131
0.220
Why?
Diverticulum
1
2024
11
0.220
Why?
Child, Preschool
21
2022
10487
0.220
Why?
Gene Products, gag
2
1994
36
0.220
Why?
Mammography
1
2025
146
0.210
Why?
Young Adult
12
2021
12349
0.210
Why?
Pregnancy
11
2023
6373
0.210
Why?
Squalene
3
2017
7
0.210
Why?
Complementarity Determining Regions
1
2002
49
0.200
Why?
Drug Resistance, Viral
2
2016
110
0.190
Why?
CD4 Lymphocyte Count
4
2017
267
0.190
Why?
Half-Life
1
2021
152
0.190
Why?
Growth Differentiation Factor 15
1
2021
39
0.190
Why?
Mitochondrial Diseases
1
2021
90
0.180
Why?
Immunization Schedule
2
2018
196
0.180
Why?
T-Lymphocytes
2
2009
1923
0.180
Why?
Drug Therapy, Combination
4
2017
1016
0.170
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
334
0.170
Why?
Fibroblast Growth Factors
1
2021
170
0.170
Why?
RNA, Small Untranslated
1
2020
15
0.170
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
15
0.170
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
186
0.160
Why?
Cytokines
2
2021
1994
0.160
Why?
Body Temperature
1
2020
212
0.160
Why?
Point Mutation
1
2020
225
0.160
Why?
Insulin Resistance
3
2019
1164
0.150
Why?
Immunologic Memory
2
2021
341
0.150
Why?
Haemophilus Vaccines
2
2018
28
0.150
Why?
Immunocompromised Host
2
2000
196
0.150
Why?
Metabolic Syndrome
1
2021
338
0.140
Why?
CD8-Positive T-Lymphocytes
2
2011
842
0.140
Why?
Interleukin-12
1
1998
118
0.140
Why?
Darunavir
1
2017
17
0.140
Why?
Mycobacterium Infections, Nontuberculous
2
2012
348
0.140
Why?
Dose-Response Relationship, Drug
1
2021
1951
0.140
Why?
Therapeutic Equipoise
1
2017
2
0.140
Why?
Interferon-gamma
5
2012
761
0.140
Why?
Uganda
1
2017
72
0.140
Why?
Immunoglobulin A
2
2017
200
0.140
Why?
Lymphopoiesis
1
2017
26
0.140
Why?
Antibody Formation
1
2018
290
0.140
Why?
High-Throughput Screening Assays
1
2018
134
0.130
Why?
Receptors, CCR5
1
2017
57
0.130
Why?
CD4-CD8 Ratio
1
2016
22
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
12
0.130
Why?
Cohort Studies
8
2025
5402
0.130
Why?
Adoption
1
2016
32
0.130
Why?
Mothers
3
2017
729
0.130
Why?
Virus Latency
1
2016
78
0.130
Why?
Adult
15
2023
35302
0.120
Why?
Continuity of Patient Care
1
2018
275
0.120
Why?
Chickenpox Vaccine
1
2015
71
0.120
Why?
Early Diagnosis
1
2016
234
0.120
Why?
Body Height
2
2017
193
0.120
Why?
Zimbabwe
2
2025
54
0.120
Why?
Gene Products, env
1
1994
6
0.120
Why?
Disease Susceptibility
1
2017
332
0.120
Why?
Haemophilus influenzae type b
1
2014
10
0.120
Why?
Bacterial Capsules
1
2014
28
0.120
Why?
Chickenpox
1
2015
80
0.120
Why?
Antibody Affinity
1
2014
59
0.110
Why?
South Africa
2
2025
192
0.110
Why?
Acquired Immunodeficiency Syndrome
2
2000
225
0.110
Why?
Cote d'Ivoire
2
2025
9
0.110
Why?
Parotitis
1
2014
6
0.110
Why?
Vaccines, Synthetic
4
2005
126
0.110
Why?
Developing Countries
1
2016
286
0.110
Why?
Lipids
1
2017
621
0.110
Why?
Cytotoxicity, Immunologic
3
2002
216
0.110
Why?
Puberty, Delayed
1
2013
5
0.110
Why?
Intestines
1
2017
344
0.110
Why?
Leukocytes, Mononuclear
4
2013
539
0.110
Why?
Retrospective Studies
8
2023
14472
0.110
Why?
Vaccines
1
2018
396
0.100
Why?
RNA-Directed DNA Polymerase
1
1993
34
0.100
Why?
Mycobacterium chelonae
1
1993
8
0.100
Why?
Patient Selection
1
2017
661
0.100
Why?
Breast Neoplasms
1
2025
2135
0.100
Why?
Lamivudine
3
2023
61
0.100
Why?
Mitochondria
2
2021
855
0.100
Why?
Cell Movement
1
2017
936
0.100
Why?
Child Development
1
2017
455
0.100
Why?
Pediatric Obesity
1
2019
570
0.100
Why?
Clinical Trials as Topic
1
2017
1003
0.100
Why?
Cardiovascular Diseases
2
2016
2001
0.100
Why?
STAT1 Transcription Factor
1
2012
70
0.090
Why?
Prospective Studies
4
2017
7069
0.090
Why?
Body Weight
2
2017
933
0.090
Why?
Polysorbates
3
2017
38
0.090
Why?
Body Fat Distribution
1
2011
49
0.090
Why?
Mycobacterium avium Complex
1
2012
85
0.090
Why?
Epitopes
2
2022
466
0.090
Why?
United States
9
2023
13840
0.090
Why?
Cost-Benefit Analysis
2
2025
569
0.090
Why?
Biomedical Research
1
2017
633
0.090
Why?
Research Design
1
2017
1036
0.090
Why?
Interleukin-2
2
2003
434
0.080
Why?
Exercise
1
2021
1918
0.080
Why?
Respiratory Tract Infections
1
2014
372
0.080
Why?
Prenatal Exposure Delayed Effects
1
2016
564
0.080
Why?
Freezing
1
2009
86
0.080
Why?
Absorptiometry, Photon
2
2025
248
0.080
Why?
Blood
1
2009
100
0.080
Why?
Algorithms
1
2016
1614
0.080
Why?
Staff Development
1
2009
57
0.080
Why?
Age Factors
4
2019
3122
0.070
Why?
Phenotype
1
2017
3051
0.070
Why?
Biomarkers
4
2021
3893
0.070
Why?
Longitudinal Studies
3
2025
2710
0.070
Why?
T-Lymphocyte Subsets
2
2002
409
0.070
Why?
Specimen Handling
1
2009
163
0.070
Why?
Lymphocyte Subsets
2
2009
85
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
820
0.070
Why?
Faculty
1
2009
135
0.070
Why?
Withholding Treatment
1
2008
70
0.070
Why?
Adipose Tissue
1
2011
589
0.070
Why?
Enterovirus A, Human
1
2007
12
0.070
Why?
Polymerase Chain Reaction
4
2011
1027
0.060
Why?
Central Nervous System Viral Diseases
1
2007
73
0.060
Why?
Flow Cytometry
3
2009
1142
0.060
Why?
DNA, Viral
2
2000
348
0.060
Why?
Academic Medical Centers
1
2009
480
0.060
Why?
False Negative Reactions
1
2025
51
0.060
Why?
Cell Line
3
2012
2741
0.060
Why?
Isoantigens
1
1984
12
0.060
Why?
Medical Audit
1
2025
77
0.060
Why?
Enterovirus Infections
1
2007
171
0.060
Why?
C-Reactive Protein
2
2021
398
0.060
Why?
Colorado
3
2023
4399
0.060
Why?
Immunity, Cellular
1
2006
263
0.060
Why?
Disease Outbreaks
1
2007
347
0.060
Why?
Follow-Up Studies
3
2021
4874
0.060
Why?
Linear Models
2
2020
816
0.060
Why?
Confusion
1
2024
26
0.050
Why?
Comorbidity
2
2021
1541
0.050
Why?
Sequence Analysis, DNA
2
2007
775
0.050
Why?
Thymus Gland
1
1984
309
0.050
Why?
Risk Factors
4
2021
9737
0.050
Why?
Tablets
1
2023
35
0.050
Why?
Constriction, Pathologic
1
2024
228
0.050
Why?
Regression Analysis
2
2021
982
0.050
Why?
Respiratory Syncytial Viruses
1
2022
52
0.050
Why?
Genes, T-Cell Receptor beta
1
2002
21
0.050
Why?
Immunophenotyping
2
1994
309
0.050
Why?
Zidovudine
2
2015
78
0.050
Why?
Clone Cells
1
2002
256
0.050
Why?
Dose-Response Relationship, Immunologic
1
2001
82
0.050
Why?
Cough
1
2022
115
0.050
Why?
Emtricitabine
1
2023
168
0.050
Why?
Vaccines, Subunit
1
2001
47
0.050
Why?
Pyridones
1
2023
158
0.050
Why?
Tenofovir
1
2023
231
0.050
Why?
Lung
1
2014
3748
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
50
0.040
Why?
Public Health Surveillance
1
2021
68
0.040
Why?
Ganciclovir
1
2000
51
0.040
Why?
Computer Simulation
1
2005
939
0.040
Why?
Adjuvants, Immunologic
2
2017
221
0.040
Why?
Africa
1
2020
99
0.040
Why?
Cross-Sectional Studies
3
2021
5045
0.040
Why?
Injections, Subcutaneous
1
2020
147
0.040
Why?
Sex Factors
2
2019
1951
0.040
Why?
Diagnostic Tests, Routine
1
2021
102
0.040
Why?
Symptom Assessment
1
2021
124
0.040
Why?
HIV Seronegativity
1
2019
25
0.040
Why?
HLA-D Antigens
1
1999
34
0.040
Why?
Risk
1
2021
853
0.040
Why?
Case-Control Studies
2
2019
3339
0.040
Why?
Prevalence
2
2016
2553
0.040
Why?
Cytomegalovirus Infections
1
2000
186
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
48
0.040
Why?
Hospitals
1
2023
637
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
41
0.040
Why?
Vaccines, Combined
1
2018
48
0.040
Why?
Cholesterol, HDL
1
2019
203
0.040
Why?
Amino Acid Sequence
1
2002
2044
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
28
0.040
Why?
Mutation
3
2018
3696
0.040
Why?
Odds Ratio
1
2021
1019
0.040
Why?
Hepatitis B Vaccines
1
2018
47
0.040
Why?
Drug Resistance, Microbial
2
2000
68
0.040
Why?
Molecular Sequence Data
1
2002
2822
0.040
Why?
Nutrition Surveys
1
2019
261
0.040
Why?
Case Management
1
2018
63
0.040
Why?
Antigens, Viral
1
1998
174
0.040
Why?
Cholesterol
1
2019
406
0.030
Why?
Cholesterol, LDL
1
2019
357
0.030
Why?
Reproducibility of Results
1
2005
3021
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
185
0.030
Why?
Disease Management
1
2021
584
0.030
Why?
Immune Tolerance
1
1999
350
0.030
Why?
Treatment Adherence and Compliance
1
2017
24
0.030
Why?
Triglycerides
1
2019
523
0.030
Why?
Lymphocyte Count
2
2009
150
0.030
Why?
Cell Division
1
1998
777
0.030
Why?
Uncertainty
1
2017
114
0.030
Why?
Treatment Failure
1
2017
338
0.030
Why?
Multicenter Studies as Topic
1
2017
286
0.030
Why?
Nevirapine
1
2015
16
0.030
Why?
Time-to-Treatment
1
2017
180
0.030
Why?
Seroepidemiologic Studies
1
2015
156
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1358
0.030
Why?
Maternal Exposure
1
2017
175
0.030
Why?
Patient Outcome Assessment
1
2016
125
0.030
Why?
Malnutrition
1
2016
79
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Treatment Outcome
2
2021
10162
0.030
Why?
Antiviral Agents
1
2000
711
0.030
Why?
Coinfection
1
2016
131
0.030
Why?
Neutropenia
1
2015
134
0.030
Why?
Vaccines, Conjugate
1
2014
63
0.030
Why?
Counseling
1
2018
384
0.030
Why?
Sexual and Gender Minorities
1
2018
193
0.030
Why?
Global Health
1
2017
330
0.030
Why?
Cells, Cultured
2
2008
4017
0.030
Why?
Anemia
1
2015
160
0.030
Why?
Maternal-Fetal Exchange
1
2014
161
0.030
Why?
Electron Transport Complex IV
1
2013
57
0.030
Why?
Electron Transport Complex I
1
2013
38
0.030
Why?
Thrombocytopenia
1
2015
185
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
Why?
HIV Reverse Transcriptase
1
1993
30
0.030
Why?
CD8 Antigens
1
1993
76
0.030
Why?
Radiography, Thoracic
1
2014
164
0.030
Why?
Severity of Illness Index
1
2021
2719
0.030
Why?
CD3 Complex
1
1993
101
0.030
Why?
Drug Administration Schedule
2
2008
764
0.020
Why?
Lymphocytes
1
1994
368
0.020
Why?
Oxidative Phosphorylation
1
2013
186
0.020
Why?
Medication Adherence
1
2017
558
0.020
Why?
Blood Pressure
1
2019
1712
0.020
Why?
DNA, Mitochondrial
1
2013
190
0.020
Why?
Blood Transfusion
1
1994
295
0.020
Why?
P-Selectin
1
2011
26
0.020
Why?
Antigens, CD
1
1994
482
0.020
Why?
E-Selectin
1
2011
53
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Tuberculosis, Pulmonary
1
1993
135
0.020
Why?
Chemokine CCL2
1
2011
117
0.020
Why?
Hospitalization
1
2021
2069
0.020
Why?
Cell Proliferation
2
2009
2345
0.020
Why?
Hyperlipidemias
1
2011
125
0.020
Why?
Fibrinogen
1
2011
164
0.020
Why?
Protein Multimerization
1
2012
178
0.020
Why?
Interferon-alpha
1
2012
193
0.020
Why?
Cross Infection
1
1993
216
0.020
Why?
Nontuberculous Mycobacteria
1
1993
199
0.020
Why?
Cell Adhesion Molecules
1
2011
173
0.020
Why?
Healthcare Disparities
1
2017
579
0.020
Why?
Infant, Premature
1
1994
538
0.020
Why?
Diagnosis, Differential
1
2014
1412
0.020
Why?
Pokeweed Mitogens
1
2009
7
0.020
Why?
L-Selectin
1
2009
24
0.020
Why?
Human Experimentation
1
2009
12
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
37
0.020
Why?
Leukocyte Common Antigens
1
2009
81
0.020
Why?
Obesity
1
2021
2864
0.020
Why?
Multivariate Analysis
1
2011
1499
0.020
Why?
Meningitis, Aseptic
1
2007
13
0.020
Why?
Virus Cultivation
1
2007
28
0.020
Why?
Interleukin-6
1
2011
715
0.020
Why?
Phosphorylation
1
2012
1686
0.020
Why?
Data Interpretation, Statistical
1
2009
335
0.020
Why?
Pregnancy Outcome
1
2010
390
0.020
Why?
Cerebrospinal Fluid
1
2007
89
0.020
Why?
Paralysis
1
2007
69
0.020
Why?
Multiple Organ Failure
1
2007
122
0.020
Why?
B-Lymphocytes
1
2012
814
0.020
Why?
Kinetics
1
2010
1624
0.020
Why?
Genotype
1
2011
1830
0.020
Why?
Respiratory System
1
2007
152
0.020
Why?
Immunoglobulin A, Secretory
1
2005
8
0.020
Why?
Cell Survival
1
2009
1076
0.020
Why?
Phosphates
1
1987
169
0.020
Why?
Muscles
1
1987
322
0.020
Why?
Encephalitis
1
2007
133
0.020
Why?
Gastrointestinal Tract
1
2007
183
0.010
Why?
Mucous Membrane
1
2005
121
0.010
Why?
Chemistry, Physical
1
1984
37
0.010
Why?
Antigen-Antibody Reactions
1
1984
51
0.010
Why?
Chemical Phenomena
1
1984
81
0.010
Why?
DNA-Binding Proteins
1
2012
1423
0.010
Why?
Myasthenia Gravis
1
1984
21
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
62
0.010
Why?
Saliva
1
2005
210
0.010
Why?
Tomography, X-Ray Computed
1
2014
2517
0.010
Why?
Tissue Distribution
1
1984
296
0.010
Why?
Aging
2
2003
1755
0.010
Why?
Blood Glucose
1
2013
2092
0.010
Why?
Epithelium
1
1984
306
0.010
Why?
Middle Aged
2
2020
30923
0.010
Why?
Body Mass Index
1
2011
2263
0.010
Why?
Infusions, Intravenous
1
2003
394
0.010
Why?
Anti-Bacterial Agents
1
1993
1705
0.010
Why?
Reference Values
1
2003
780
0.010
Why?
Mice, Inbred BALB C
1
1984
1227
0.010
Why?
Suspensions
1
2000
36
0.010
Why?
Capsules
1
2000
38
0.010
Why?
Urban Population
1
2003
441
0.010
Why?
Drug Tolerance
1
2000
84
0.010
Why?
Cytomegalovirus
1
2000
152
0.010
Why?
Signal Transduction
1
2012
4825
0.010
Why?
Administration, Oral
1
2000
767
0.010
Why?
Epithelial Cells
1
1984
1043
0.010
Why?
Immunization
1
2000
411
0.010
Why?
Time Factors
1
2008
6506
0.010
Why?
Macrophages
1
1984
1464
0.010
Why?
Recombinant Proteins
1
2000
1291
0.010
Why?
Mice
1
1984
16620
0.000
Why?
Tail
1
1987
28
0.000
Why?
Phosphocreatine
1
1987
40
0.000
Why?
Salamandridae
1
1987
26
0.000
Why?
Animals
2
1987
34647
0.000
Why?
Aged
1
1984
21976
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
510
0.000
Why?
Adenosine Triphosphate
1
1987
469
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)